Skip to content
Cambridge
Design
Partnership
    • Consumer Healthcare
    • Consumer Technology
    • Diagnostics
    • Drug Delivery
    • FMCG
    • Industrial
    • Medical Therapy
    • Tobacco Harm Reduction
    • Applied Science
    • Data Science & Digital Service
    • Insight & Strategy
    • People-Centered Design
    • Product Engineering
    • Quality & Regulatory Affairs
    • Sustainability
    • Testing & Evaluation
    • Transfer to Manufacture
  • Our Work
  • Insights
  • How we work
  • Company
    • Benefits
    • Bourn Quarter
    • Early careers
    • Join our team
    • FAQs & top tips
    • What to expect
  • Contact

Category: Analysis

Analysis

Single-Use Endoscopes: A Greener Solution?

5 Sep 2024

Sergio explores single-use endoscopes and our framework for designing a greener solution. Focusing on sustainability, balancing environmental benefits with clinical outcomes and commercial opportunities through creative, data-driven strategies.

Members of the European Pharmaceutical Aerosol Group (EPAG) at Cambridge Design Partnership’s UK headquarters.
Analysis

Advancements, Challenges, and Opportunities in Developing Respiratory Drug Delivery Devices

30 Aug 2024

Insights from Industry Experts on Training for Patient Technique, the Value of Connected Devices, and the Shift to Low GWP pMDIs.

Analysis

Introducing the World’s First ‘Touchable Memory’: A Device Shining a Light on Usher Syndrome

2 Apr 2024

We are honored to announce our involvement in a remarkable awareness campaign with Cure Usher, Havas Lynx, and Push Films: the world's first 'touchable memory' device. 

CDP Expertise on board
Analysis

Expertise on Board: Does Your Team Have What It Takes to Accelerate Time to Market?  

20 Feb 2024

Multidisciplinary teams with diverse industry experience can dramatically speed up your new product development, securing you first-mover advantage.

Analysis

Exploring the potential (and pitfalls) in on-body large-volume injectors

16 Feb 2024

In a recent Q&A with Healthcare Packaging, CDP’s Clare Beddoes and Stephen Augustyn discuss the latest trends in on-body large volume injectors (LVIs) and what they expect to see in 2024.

Innovations in Oncology
Analysis

Innovations in Oncology: Past, Present, Future

2 Feb 2024

Explore five exciting developments in the field of oncology and how advances in diagnostics, data analytics, cell biology and delivery devices are enabling oncology companies to bring the hope of longer, healthier lives.

Bespoke device for targeted intranasal delivery
Analysis

Taking a drug to first-in-human trials in a bespoke device for targeted intranasal delivery

19 Dec 2023

Mark Allen, Andrew Fiorini, and Shai Assia discuss the need to develop delivery devices early when formulating nasally delivered drugs for systemic and local action, and a method by which the route to clinic can be made easier, faster and cheaper.

Five hurdles to digital health innovation in the UK
Analysis

Five hurdles to digital health innovation in the UK (and how to overcome them)

30 Nov 2023

In a recent investigation on digital health innovation in the UK, we uncovered several hurdles that hinder progress. Here, we outline five and signpost resources to help innovators overcome them.

New frontiers in implantable neuromodulation therapies
Analysis

New frontiers in implantable neuromodulation therapies

10 Nov 2023

Sergio and Alejandra explore emerging implantable neuromodulation therapies that are opening new possibilities in the rapidly evolving field.

How data and AI are changing bioprocessing
Analysis

How data and AI are changing bioprocessing – and why it’s needed

30 Oct 2023

Bioprocessing technology is developing rapidly due to the automation of data collection and processing. But as Richard Owen (Head of Biology) and Arianna Rech (Bioprocessing Lead) explain, there is more that needs to be done to keep up with industry demand.

Insights into GenAI product owner's perspective - Cambridge Design Partnership
Analysis

The Chatbot’s perspective: Five practical insights to accelerating innovation with GenAI

19 Oct 2023

In the fourth of our GenAI series, we’ve prompted the LLM to give us insights. So for the Chatbot’s perspective, here is the response from GPT-4 - verbatim.

The data scientist’s perspective
Analysis

The data scientist’s perspective: Five practical insights to accelerating innovation with GenAI

18 Oct 2023

In our third article of the series, we explore how data scientists can extract valuable insights and drive innovation using GenAI and LLMs.

Posts navigation

  • «
  • 1
  • 2
  • 3
  • 4
  • …
  • 20
  • »
US OFFICE
801 West Morgan Street
Suite 120, Raleigh, NC 27603
+1 (919) 901 0909
UK OFFICE
Bourn Quarter, Wellington Way, Caldecote, Cambridge CB23 7FW
+44 (0)1223 264428
Cookie Policy | Privacy Policy | UK Gender Pay Gap
© Cambridge Design Partnership Ltd 2025. Registered in England and Wales No. GB6786351.